RNIB requires wet AMD patients for research

Article

The Royal National Institute of the Blind (RNIB) require 300 patients and carers to participate in two research projects.

The Royal National Institute of the Blind (RNIB) require 300 patients and carers to participate in two research projects.

They need 100 wet AMD patients, 100 carers of people with wet AMD and 100 patients with cataract. The aim of the research is to assess the impact of restrictions on treatment access and to ask eye health specialists how their services are delivered.

Patients must have been diagnosed and treated for either wet AMD or cataracts in the last three years. This can include those who are still undergoing treatment or have completed it.

Research will be conducted confidentially over the telephone and reports will be published in Spring 2013. The results will enable the RNIB to campaign for primary care trusts to alter their policies and improve treatment access.

To enter patients who are interested in taking part please email campaigns@rnib.org.uk by Friday 14th December 2012.

For further information visit the website.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.